Geode Capital Management, LLC Hcw Biologics Inc. Transaction History
Geode Capital Management, LLC
- $1.21 Trillion
- Q3 2024
A detailed history of Geode Capital Management, LLC transactions in Hcw Biologics Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 183,259 shares of HCWB stock, worth $75,136. This represents 0.0% of its overall portfolio holdings.
Number of Shares
183,259
Previous 170,385
7.56%
Holding current value
$75,136
Previous $110,000
10.91%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding HCWB
# of Institutions
17Shares Held
1.16MCall Options Held
0Put Options Held
0-
Avantax Planning Partners, Inc.280KShares$114,6110.01% of portfolio
-
High Tower Advisors, LLC Chicago, IL181KShares$74,1320.0% of portfolio
-
Cresset Asset Management, LLC Chicago, IL132KShares$54,1150.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX84.7KShares$34,7270.0% of portfolio
-
Pullen Investment Management, LLC Bradenton, FL75.1KShares$30,7970.03% of portfolio
About HCW Biologics Inc.
- Ticker HCWB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,833,100
- Market Cap $14.7M
- Description
- HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal...